Genetic Transmission of Cytochrome P450 2D6 (CYP2D6) Ultrarapid Metabolism: Implications for Breastfeeding Women taking Codeine

被引：19

作者：

Madadi, Parvaz ^{[1
,2
]}

Ciszkowski, Catherine ^{[3
,4
]}

Gaedigk, Andrea ^{[5
]}

Leeder, J. Steven ^{[5
]}

Teitelbaum, Ronni ^{[6
]}

Chitayat, David ^{[6
]}

Koren, Gideon ^{[1
,2
,3
,4
]}

机构：

[1] Hosp Sick Children, Clin Pharmacol & Toxicol, Toronto, ON, Canada

[2] Hosp Sick Children, Motherisk Program, Toronto, ON, Canada

[3] Univ Western Ontario, Schulich Sch Med & Dent, Mol Toxicol, London, ON, Canada

[4] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada

[5] Childrens Mercy Hosp & Clin, Sect Clin Pharmacol & Expt Therapeut, Kansas City, MO USA

[6] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON, Canada

来源：

CURRENT DRUG SAFETY | 2011年 / 6卷 / 01期

关键词：

CYP2D6; duplication; codeine; breastmilk; ultrarapid metabolism; pedigree;

D O I：

10.2174/157488611794479991

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The pro-drug codeine is commonly prescribed for postpartum pain relief in North America. The safety of codeine during breastfeeding is related in part to the extent of the active morphine metabolite catalyzed from codeine via the cytochrome P450 2D6 ( CYP2D6) enzyme. In mothers who have greater than two functional copies of the CYP2D6 gene (CYP2D6 ultrarapid metabolism phenotype; UM) a substantially higher proportion of morphine is produced. Label changes on codeine-containing medications will highlight the risks associated with this genotype for breastfeeding mothers, but are not supported by translation strategies on how to incorporate this pharmacogenetic knowledge into clinical practice. To address the immediate issue of CYP2D6 UM inheritance in family members of a breastfed infant who succumbed to fatal opioid intoxication and whose codeine-prescribed mother was a CYP2D6 UM, we constructed a pedigree. While the pedigree approach is helpful to aid diagnosis, identify other at risk family members, and simplify pharmacogenetic analysis, its clinical usefulness is dependant on an institutional framework which is not available in most centers at this time.

引用

页码：36 / 39

页数：4

共 32 条

[1] PREVALENCE OF CYP2D6 GENE DUPLICATION AND ITS REPERCUSSION ON THE OXIDATIVE PHENOTYPE IN A WHITE-POPULATION [J].

AGUNDEZ, JAG ;

LEDESMA, MC ;

LADERO, JM ;

BENITEZ, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (03) :265-269

[2]

Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441

[3] Postmenstrual age and CYP2D6 polymorphisms determine tramadol O-demethylation in critically I11 neonates and infants [J].

Allegaert, Karel ;

Van Schaik, Ron H. N. ;

Vermeersch, Steve ;

Verbesselt, Rene ;

Cossey, Veerle ;

Vanhole, Christine ;

Van Fessem, Marianne ;

De Hoon, Jan ;

Van den Anker, John N. .

PEDIATRIC RESEARCH, 2008, 63 (06) :674-679

[4]

BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073

[5] Ontogeny of dextromethorphan O- and N-demethylation in the first year of life [J].

Blake, M. J. ;

Gaedigk, A. ;

Pearce, R. E. ;

Bomgaars, L. R. ;

Christensen, M. L. ;

Stowe, C. ;

James, L. P. ;

Wilson, J. T. ;

Kearns, G. L. ;

Leeder, J. S. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :510-516

[6]

DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516

[7] Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine [J].

Dalen, P ;

Frengell, C ;

Dahl, ML ;

Sjoqvist, F .

THERAPEUTIC DRUG MONITORING, 1997, 19 (05) :543-544

[8] Glucuronidation in humans - Pharmacogenetic and developmental aspects [J].

de Wildt, SN ;

Kearns, GL ;

Leeder, JS ;

van den Anker, JN .

CLINICAL PHARMACOKINETICS, 1999, 36 (06) :439-452

[9] Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events [J].

Gaedigk, A. ;

Ndjountche, L. ;

Divakaran, K. ;

Bradford, L. DiAnne ;

Zineh, I. ;

Oberlander, T. F. ;

Brousseau, D. C. ;

McCarver, D. G. ;

Johnson, J. A. ;

Alander, S. W. ;

Riggs, K. Wayne ;

Leeder, J. Steven .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :242-251

[10] Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans [J].

Gaedigk, A ;

Bradford, LD ;

Marcucci, KA ;

Leeder, JS .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (01) :76-89

← 1 2 3 4 →